| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12Cr | ||
| +2.16% | +3.17% | +43.57% | +160.28% | 1,03500Cr | ||
| -0.07% | +4.45% | +53.50% | +48.95% | 57TCr | ||
| -0.08% | -0.08% | +17.37% | +62.66% | 40TCr | ||
| +0.52% | +0.77% | +21.19% | +15.95% | 32TCr | ||
| +0.01% | -1.91% | +23.25% | +14.91% | 28TCr | ||
| +0.67% | +3.85% | +24.93% | +34.87% | 28TCr | ||
| -0.30% | +3.88% | -45.58% | -48.35% | 19TCr | ||
| +4.84% | +2.45% | +21.33% | +61.85% | 19TCr | ||
| +3.61% | -2.56% | +15.16% | +61.12% | 16TCr | ||
| Average | +0.45% | +1.68% | +19.41% | +45.81% | 38.11TCr | |
| Weighted average by Cap. | +0.28% | +2.39% | +29.36% | +72.89% |
Employees
1,178
Sector
Pharmaceuticals
















